IL-28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
Takeshi TerashimaMasao HondaTadashi ToyamaTetsuro ShimakamiRyogo ShimizuHajime TakatoriKuniaki AraiKazunori KawaguchiKazuya KitamuraTaro YamashitaYoshio SakaiTatsuya YamashitaEishiro MizukoshiShuichi KanekoPublished in: Journal of gastroenterology and hepatology (2020)
The IL-28B SNP (rs8099917) will serve as a useful predictor of the outcomes of patients with advanced HCC treated with HAIC.